Scott Holmes - Chief Financial Officer, Keryx Biopharmaceuticals Inc

As of December 13, 2018


Scott Holmes Net Worth

  • Net worth is estimated to be at least $2.95M
  • Owns at least 162,956 units of Keryx Biopharmaceuticals Inc stock
  • Sold an estimated value of $200.91K in the last 3 years at Keryx Biopharmaceuticals Inc

Scott Holmes Trading

  • Largest purchase of shares was 5,000 units , worth over $28.59K on August 24, 2015
  • Largest sale of shares was 8,447 units , worth over $39.28K on January 31, 2017
  • In total has made about 18 transactions over 3 years
  • Usually trades in August, with the busiest year in 2017
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Scott Holmes Mailing Address

  • Mailing address is C/o Keryx Biopharmaceuticals Inc 1 Marina Park Dr., 10th Floor Boston MA 02210 MA

Keryx Biopharmaceuticals Inc Insider Trading

  • The most recent transaction was 111,115 units sold on December 13, 2018 by Christine Carberry worth over $33.71K
  • In the last 4 years, insiders at Keryx Biopharmaceuticals Inc sold an estimated value of $4.69M and bought an estimated value of $165.13M
  • The most active traders are Greg Madison, President and CEO,  John Neylan, Chief Medical Officer,  and Brian Adams, General Counsel and Secretary
  • Insider trading is most common in January, with the busiest year in 2018

KERYX BIOPHARMACEUTICALS INC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1